Asthma study aided by Pitt, Allegheny Health eyes acetaminophen link – Tribune-Review

Asthma study aided by Pitt, Allegheny Health eyes acetaminophen link
Tribune-Review
“I don't think the entire asthma epidemic is due to Tylenol. But I think it may have significantly contributed,” said McBride, a vice chairman at Akron Children's Hospital in Ohio who found “incredible consistency” in reported patterns of acetaminophen

View full post on asthma – Google News

Pittsburgh part of study to research treatments for black asthma patients – Tribune-Review

Pittsburgh part of study to research treatments for black asthma patients
Tribune-Review
Research that began this month could lead to better asthma treatments for black people, who tend to develop more severe symptoms from the respiratory disease, a University of Pittsburgh researcher said. The yearlong study financed through the National 

View full post on asthma – Google News

Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Patients With Asthma

Condition:   Asthma
Interventions:   Drug: Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX;   Drug: SYMBICORT TURBOHALER budesonide and formoterol fumarate
Sponsors:   Teva Pharmaceutical Industries;   Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified February 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Asthma study aided by Pitt, Allegheny Health Network eyes acetaminophen link – Tribune-Review

Asthma study aided by Pitt, Allegheny Health Network eyes acetaminophen link
Tribune-Review
But I think it may have significantly contributed,” said McBride, a vice chairman at Akron Children's Hospital in Ohio who found “incredible consistency” in reported patterns of acetaminophen use and bad asthma symptoms. “I just think it's important

View full post on asthma – Google News

Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD

Conditions:   Pulmonary Disease, Chronic Obstructive;   Asthma
Interventions:   Drug: LAS190792 Dose 1;   Drug: LAS190792 Dose 2;   Drug: LAS190792 Dose 3;   Drug: LAS190792 Dose 4;   Drug: LAS190792 Dose 5;   Drug: LAS190792 Dose 6;   Drug: LAS190792 Dose 1 (Part 2);   Drug: LAS190792 Dose 2 (Part 2);   Drug: Tiotropium 18 ?g;   Drug: Indacaterol 150 ?g;   Drug: Placebo
Sponsor:   Almirall, S.A.
Recruiting – verified February 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

NIH study seeks to improve asthma therapy for African-Americans – National Institutes of Health (press release)

NIH study seeks to improve asthma therapy for African-Americans
National Institutes of Health (press release)
Researchers will enroll around 500 African-American children and adults who have asthma in a multi-center clinical trial to assess how they react to therapies and to explore the role of genetics in determining the response to asthma treatment. This new 

View full post on asthma – Google News